Title:
QUINOLINE COMPOUND AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/143623
Kind Code:
A1
Abstract:
Disclosed are a quinoline compound and the use thereof. The quinoline compound is a compound as represented by formula (I), formula (II) or formula (III), a pharmaceutically acceptable salt thereof, a solvate thereof, a stereoisomer thereof, a tautomer thereof, a prodrug thereof, a metabolite thereof, or an isotope compound thereof.
Inventors:
ZHANG CHAOXIN (CN)
XIA GUANGXIN (CN)
LI ZHILONG (CN)
PENG YAYUAN (CN)
KE YING (CN)
MAO HAIBIN (CN)
FU YUHONG (CN)
XIA GUANGXIN (CN)
LI ZHILONG (CN)
PENG YAYUAN (CN)
KE YING (CN)
MAO HAIBIN (CN)
FU YUHONG (CN)
Application Number:
PCT/CN2023/073901
Publication Date:
August 03, 2023
Filing Date:
January 30, 2023
Export Citation:
Assignee:
SHANGHAI PHARMACEUTICALS HOLDING CO LTD (CN)
International Classes:
C07D519/00; A61K31/553; A61P35/00; C07D403/14; C07D413/14; C07D491/107; C07D498/22
Domestic Patent References:
| WO2023001141A1 | 2023-01-26 | |||
| WO2022173678A1 | 2022-08-18 | |||
| WO2022268051A1 | 2022-12-29 | |||
| WO2022199587A1 | 2022-09-29 | |||
| WO2022194245A1 | 2022-09-22 | |||
| WO2022188729A1 | 2022-09-15 | |||
| WO2022206723A1 | 2022-10-06 | |||
| WO2021093758A1 | 2021-05-20 |
Foreign References:
| CN113087700A | 2021-07-09 | |||
| CN115557974A | 2023-01-03 | |||
| CN114805311A | 2022-07-29 | |||
| CN112745335A | 2021-05-04 |
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF: